Hirofumi Nakano

Analysis of the cost-effectiveness of treatment strategies for CML with incorporation of treatment discontinuation

Chihiro Yamamoto, Hirotomo Nakashima, Takashi Ikeda et al. · Blood Advances · 2019 · 38 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +9

Comprehensive Analysis of the Activation and Proliferation Kinetics and Effector Functions of Human Lymphocytes, and Antigen Presentation Capacity of Antigen-Presenting Cells in Xenogeneic Graft-Versus-Host Disease

Yasufumi Kawasaki, Kazuya Sato, Hiroko Hayakawa et al. · Biology of Blood and Marrow Transplantation · 2018 · 31 citations · Full text

Life Sciences, Immunology, Pathobiology +11

Daratumumab in first-line therapy is cost-effective in transplant-eligible patients with newly diagnosed myeloma

Chihiro Yamamoto, Daisuke Minakata, Shunsuke Koyama et al. · Blood · 2022 · 24 citations · Full text

Medicine, Oncology, Pharmacotherapy +7

False-positive Aspergillus galactomannan and its kinetics in allogeneic hematopoietic stem cell transplantation

Shun‐ichi Kimura, Yu Akahoshi, Hirofumi Nakano et al. · Journal of Infection · 2015 · 21 citations

Medicine, Hematology, Immunology +13

Possible clinical effects of molecular hydrogen (H2) delivery during hemodialysis in chronic dialysis patients: Interim analysis in a 12 month observation

Masaaki Nakayama, Noritomo Itami, Hodaka Suzuki et al. · PLoS ONE · 2017 · 18 citations · Full text

Medicine, Nephrology, Pharmacology +17